1型糖尿病进展中葡萄糖反应曲线的病理演变:TrialNet预防路径研究
该研究在抗体阳性的TrialNet预防路径人群中纵向分析口服葡萄糖耐量试验的葡萄糖反应曲线变化。进展为1型糖尿病者从双相转为单相曲线更常见(75.4% vs 51.0%,P<0.001),诊断时47.7%为单调曲线,且曲线变化与β细胞功能下降相关。
要点
- 抗体阳性者进展为1型糖尿病时,葡萄糖反应曲线呈双相→单相→单调的特征性演变。
- 进展者双相转单相比例高于非进展者(75.4% vs 51.0%,P<0.001),单相转双相比例更低(12.6% vs 30.6%,P<0.001)。
- 曲线变化对应β细胞功能下降,早期C肽反应在进展者中降低。
核心结论
- 葡萄糖反应曲线在1型糖尿病进展中呈现双相→单相→单调的特征性变化。
- 这些曲线变化与β细胞功能下降相对应。
研究设计与样本
- 纵向分析TrialNet预防路径研究中抗体阳性且多次行OGTT的个体。
- 比较进展者(n=298)与非进展者(n=2,216)从首次至末次OGTT的曲线变化。
- 在进展者中分析末次OGTT至诊断时OGTT的曲线变化。
主要发现
- 进展者从双相转为单相曲线较非进展者更常见(75.4% vs 51.0%,P<0.001)。
- 进展者从单相转为双相曲线较非进展者更少见(12.6% vs 30.6%,P<0.001)。
- 诊断时47.7%的进展者呈单调曲线。
- 进展者从双相转单相时早期(30-0 min)C肽反应下降(P<0.001)。
- 进展者从单相转单调时早期C肽反应下降(P<0.001)。
临床怎么用
- 可利用OGTT葡萄糖反应曲线形态变化辅助评估1型糖尿病进展风险。
- 曲线由双相转为单相或单调提示β细胞功能下降,需加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Glucose response curves (GRCs) during oral glucose tolerance tests (OGTTs) are predictive of type 1 diabetes. We performed a longitudinal analysis in pancreatic autoantibody-positive individuals to assess 1) characteristic GRC changes during progression to type 1 diabetes and 2) GRC changes in relation to β-cell function changes and to combined glucose and C-peptide response curve (GCRC) changes. RESEARCH DESIGN AND METHODS: Among antibody-positive individuals with serial OGTTs in the TrialNet Pathway to Prevention study, GRC changes from first to last OGTTs were compared between progressors (n = 298) to type 1 diabetes and nonprogressors (n = 2,216). GRC changes from last OGTT before diagnosis to diagnostic OGTTs were studied in progressors. RESULTS: GRCs changed more frequently from biphasic (two peaks) to monophasic (one peak) GRCs between first and last OGTTs in progressors than in nonprogressors (75.4% vs. 51.0%, respectively; P < 0.001). In contrast, GRCs of progressors changed less frequently from monophasic to biphasic than those of nonprogressors (12.6% vs. 30.6%; P < 0.001). Monotonic (continuous increase) GRCs were present in 47.7% of progressors at diagnosis. The early (30-0 min) C-peptide response decreased in progressors with GRCs changing from biphasic to monophasic between first and last OGTTs (P < 0.001) and from monophasic to monotonic between last and diagnostic OGTTs (P < 0.001). Conversely, the early C-peptide response increased among nonprogressors with GRCs changing from monophasic to biphasic (P < 0.001). Changes in GRCs were related to changes in GCRCs. CONCLUSIONS: Characteristic GRC changes, biphasic to monophasic to monotonic, occur during the progression to type 1 diabetes. These GRC changes correspond to decreasing β-cell function.
引用
- Ismail HM, Cleves MA, Xu P, et al. The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study. Diabetes Care. 2020. PMID: 32900788. doi:10.2337/dc20-0701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。